Suppr超能文献

APOBEC3 多聚化与活细胞中 HIV-1 的包装和限制活性相关。

APOBEC3 multimerization correlates with HIV-1 packaging and restriction activity in living cells.

机构信息

School of Physics and Astronomy, University of Minnesota, 116 Church Street Southeast, Minneapolis, MN 55455, USA; Institute for Molecular Virology, University of Minnesota, 515 Delaware Street Southeast, Minneapolis, MN 55455, USA.

Institute for Molecular Virology, University of Minnesota, 515 Delaware Street Southeast, Minneapolis, MN 55455, USA; Department of Biochemistry, Molecular Biology and Biophysics, 321 Church Street Southeast, Minneapolis, MN 55455, USA.

出版信息

J Mol Biol. 2014 Mar 20;426(6):1296-307. doi: 10.1016/j.jmb.2013.12.014. Epub 2013 Dec 17.

Abstract

APOBEC3G belongs to a family of DNA cytosine deaminases that are involved in the restriction of a broad number of retroviruses including human immunodeficiency virus type 1 (HIV-1). Prior studies have identified two distinct mechanistic steps in Vif-deficient HIV-1 restriction: packaging into virions and deaminating viral cDNA. APOBEC3A, for example, although highly active, is not packaged and is therefore not restrictive. APOBEC3G, on the other hand, although having weaker enzymatic activity, is packaged into virions and is strongly restrictive. Although a number of studies have described the propensity for APOBEC3 oligomerization, its relevance to HIV-1 restriction remains unclear. Here, we address this problem by examining APOBEC3 oligomerization in living cells using molecular brightness analysis. We find that APOBEC3G forms high-order multimers as a function of protein concentration. In contrast, APOBEC3A, APOBEC3C and APOBEC2 are monomers at all tested concentrations. Among other members of the APOBEC3 family, we show that the multimerization propensities of APOBEC3B, APOBEC3D, APOBEC3F and APOBEC3H (haplotype II) bear more resemblance to APOBEC3G than to APOBEC3A/3C/2. Prior studies have shown that all of these multimerizing APOBEC3 proteins, but not the monomeric family members, have the capacity to package into HIV-1 particles and restrict viral infectivity. This correlation between oligomerization and restriction is further evidenced by two different APOBEC3G mutants, which are each compromised for multimerization, packaging and HIV-1 restriction. Overall, our results imply that multimerization of APOBEC3 proteins may be related to the packaging mechanism and ultimately to virus restriction.

摘要

APOBEC3G 属于 DNA 胞嘧啶脱氨酶家族,该家族参与限制多种逆转录病毒,包括人类免疫缺陷病毒 1 型(HIV-1)。先前的研究已经确定了 Vif 缺陷型 HIV-1 限制的两个不同的机制步骤:包装到病毒粒子中和脱氨病毒 cDNA。例如,APOBEC3A 虽然具有高度活性,但不被包装,因此不具有限制性。另一方面,APOBEC3G 虽然酶活性较弱,但被包装到病毒粒子中,具有很强的限制性。尽管有许多研究描述了 APOBEC3 寡聚化的倾向,但它与 HIV-1 限制的相关性仍不清楚。在这里,我们通过使用分子亮度分析在活细胞中检查 APOBEC3 寡聚化来解决这个问题。我们发现 APOBEC3G 作为蛋白质浓度的函数形成高序多聚体。相比之下,APOBEC3A、APOBEC3C 和 APOBEC2 在所有测试浓度下均为单体。在 APOBEC3 家族的其他成员中,我们表明 APOBEC3B、APOBEC3D、APOBEC3F 和 APOBEC3H(II 型单倍型)的多聚化倾向与 APOBEC3G 比 APOBEC3A/3C/2 更相似。先前的研究表明,所有这些多聚化的 APOBEC3 蛋白,但不是单体家族成员,都有能力包装到 HIV-1 颗粒中并限制病毒感染性。这种寡聚化与限制之间的相关性进一步通过两种不同的 APOBEC3G 突变体得到证实,这两种突变体都不能进行多聚化、包装和 HIV-1 限制。总的来说,我们的结果表明 APOBEC3 蛋白的多聚化可能与包装机制有关,最终与病毒限制有关。

相似文献

1
APOBEC3 multimerization correlates with HIV-1 packaging and restriction activity in living cells.
J Mol Biol. 2014 Mar 20;426(6):1296-307. doi: 10.1016/j.jmb.2013.12.014. Epub 2013 Dec 17.
2
Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
J Virol. 2017 Jan 18;91(3). doi: 10.1128/JVI.02230-16. Print 2017 Feb 1.
5
Polymorphisms of the cytidine deaminase APOBEC3F have different HIV-1 restriction efficiencies.
Virology. 2019 Jan 15;527:21-31. doi: 10.1016/j.virol.2018.11.004. Epub 2018 Nov 15.
6
Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n.
PLoS Pathog. 2012;8(7):e1002800. doi: 10.1371/journal.ppat.1002800. Epub 2012 Jul 12.
7
Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.
J Mol Biol. 2014 Mar 20;426(6):1220-45. doi: 10.1016/j.jmb.2013.10.033. Epub 2013 Nov 2.
8
Catalytic activity of APOBEC3F is required for efficient restriction of Vif-deficient human immunodeficiency virus.
Virology. 2014 Feb;450-451:49-54. doi: 10.1016/j.virol.2013.11.041. Epub 2013 Dec 20.
9
The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H.
J Virol. 2012 Jan;86(1):49-59. doi: 10.1128/JVI.06082-11. Epub 2011 Oct 19.

引用本文的文献

1
Analysis of Arc/Arg3.1 Oligomerization In Vitro and in Living Cells.
Int J Mol Sci. 2024 Jun 12;25(12):6454. doi: 10.3390/ijms25126454.
2
Engineered deaminases as a key component of DNA and RNA editing tools.
Mol Ther Nucleic Acids. 2023 Oct 20;34:102062. doi: 10.1016/j.omtn.2023.102062. eCollection 2023 Dec 12.
3
Structural basis of HIV-1 Vif-mediated E3 ligase targeting of host APOBEC3H.
Nat Commun. 2023 Aug 28;14(1):5241. doi: 10.1038/s41467-023-40955-x.
5
Partitioning of ribonucleoprotein complexes from the cellular actin cortex.
Sci Adv. 2022 Aug 19;8(33):eabj3236. doi: 10.1126/sciadv.abj3236.
6
APOBEC3: Friend or Foe in Human Papillomavirus Infection and Oncogenesis?
Annu Rev Virol. 2022 Sep 29;9(1):375-395. doi: 10.1146/annurev-virology-092920-030354. Epub 2022 Jun 7.
7
HIV-1 Vif Gained Breadth in APOBEC3G Specificity after Cross-Species Transmission of Its Precursors.
J Virol. 2022 Feb 23;96(4):e0207121. doi: 10.1128/JVI.02071-21. Epub 2021 Dec 15.
8
Highly-potent, synthetic APOBEC3s restrict HIV-1 through deamination-independent mechanisms.
PLoS Pathog. 2021 Jun 25;17(6):e1009523. doi: 10.1371/journal.ppat.1009523. eCollection 2021 Jun.
9
Degradation-Independent Inhibition of APOBEC3G by the HIV-1 Vif Protein.
Viruses. 2021 Apr 3;13(4):617. doi: 10.3390/v13040617.
10
Foamy Viruses, Bet, and APOBEC3 Restriction.
Viruses. 2021 Mar 18;13(3):504. doi: 10.3390/v13030504.

本文引用的文献

1
Binding of RNA by APOBEC3G controls deamination-independent restriction of retroviruses.
Nucleic Acids Res. 2013 Aug;41(15):7438-52. doi: 10.1093/nar/gkt527. Epub 2013 Jun 12.
2
Prototype foamy virus Bet impairs the dimerization and cytosolic solubility of human APOBEC3G.
J Virol. 2013 Aug;87(16):9030-40. doi: 10.1128/JVI.03385-12. Epub 2013 Jun 12.
4
Crystal structure of the DNA cytosine deaminase APOBEC3F: the catalytically active and HIV-1 Vif-binding domain.
Structure. 2013 Jun 4;21(6):1042-50. doi: 10.1016/j.str.2013.04.010. Epub 2013 May 16.
5
Endogenous APOBEC3A DNA cytosine deaminase is cytoplasmic and nongenotoxic.
J Biol Chem. 2013 Jun 14;288(24):17253-60. doi: 10.1074/jbc.M113.458661. Epub 2013 May 2.
6
Brightness analysis.
Methods Enzymol. 2013;518:71-98. doi: 10.1016/B978-0-12-388422-0.00004-2.
7
40 years of FCS: how it all began.
Methods Enzymol. 2013;518:1-10. doi: 10.1016/B978-0-12-388422-0.00001-7.
8
Host restriction factors in retroviral infection: promises in virus-host interaction.
Retrovirology. 2012 Dec 20;9:112. doi: 10.1186/1742-4690-9-112.
9
The restriction factors of human immunodeficiency virus.
J Biol Chem. 2012 Nov 30;287(49):40875-83. doi: 10.1074/jbc.R112.416925. Epub 2012 Oct 5.
10
Human Tribbles 3 protects nuclear DNA from cytidine deamination by APOBEC3A.
J Biol Chem. 2012 Nov 9;287(46):39182-92. doi: 10.1074/jbc.M112.372722. Epub 2012 Sep 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验